[HTML][HTML] Residual disease associated with suboptimal treatment response in patients with psoriatic arthritis: a systematic review of real-world evidence

LC Coates, M de Wit, A Buchanan-Hughes… - Rheumatology and …, 2022 - Springer
Objective This systematic literature review aimed to identify and summarise real-world
observational studies reporting the type, prevalence and/or severity of residual symptoms …

Outcome measures used in psoriatic arthritis registries and cohorts: a systematic literature review of 27 registries or 16,183 patients

K Aouad, G Moysidou, A Rakotozafiarison… - Seminars in Arthritis and …, 2021 - Elsevier
Abstract Introduction Psoriatic arthritis (PsA) is a multidimensional inflammatory disease for
which multiple outcome measures can be used to assess disease activity. In 2006, the …

Initiating evaluation of composite outcome measures for psoriatic arthritis: 2022 updates from the GRAPPA-OMERACT working group

YY Leung, W Tillett, M de Wit, AM Orbai… - The Journal of …, 2023 - jrheum.org
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)–
Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) working group …

OMERACT Filter 2.1 instrument selection for physical function domain in psoriatic arthritis: Provisional endorsement for HAQ-DI and SF-36 PF

YY Leung, AM Orbai, P Hojgaard, R Holland… - Seminars in arthritis and …, 2021 - Elsevier
Objectives Physical function is one of the core domains to be measured in all trials in
psoriatic arthritis (PsA). We aimed to evaluate two instruments for physical function in PsA …

Performance of 3 composite measures for disease activity in peripheral spondyloarthritis

E Beckers, M Been, C Webers, A Boonen… - The Journal of …, 2022 - jrheum.org
Objective To investigate concurrent validity and discrimination of the Disease Activity Index
for Psoriatic Arthritis (DAPSA) score, Psoriatic Arthritis Disease Activity Score (PASDAS) …

Composite measures for routine clinical practice in psoriatic arthritis: testing of shortened versions in a UK multicenter study

W Tillett, O FitzGerald, LC Coates, J Packham… - The Journal of …, 2021 - jrheum.org
Objective To test shortened versions of the psoriatic arthritis (PsA) composite measures for
use in routine clinical practice. Methods Clinical and patient-reported outcome measures …

Construct validity and responsiveness of feasible composite disease activity measures for use in daily clinical practice in patients with psoriatic arthritis

FR Kasiem, MR Kok, JJ Luime, I Tchetverikov… - RMD open, 2023 - rmdopen.bmj.com
Objective There is a need for a widely accepted comprehensive disease activity measure for
use in daily practice in patients with psoriatic arthritis (PsA). For this reason, the 3-item …

Test-retest reliability for HAQ-DI and SF-36 PF for the measurement of physical function in psoriatic arthritis

YY Leung, W Tillett, P Hojgaard, AM Orbai… - The Journal of …, 2021 - jrheum.org
Objective. Due to no existing data, we aimed to derive evidence to support test-retest
reliability for the Health Assessment Questionnaire–Disability Index (HAQ-DI) and 36-item …

GRAPPA 2021 pilot grant award reports

FR Kasiem, D Yamada, J Marin, M Vis… - The Journal of …, 2023 - jrheum.org
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) pilot
grant awards help support young researchers starting their careers while also encouraging …

Evaluation and validation of a patient-completed psoriatic arthritis flare questionnaire

PS Helliwell, W Tillett, R Waxman, LC Coates… - The Journal of …, 2021 - jrheum.org
Objective Evaluation of a psoriatic arthritis (PsA), multidimensional, patient-completed
disease flare questionnaire (FLARE). Methods The FLARE questionnaire was administered …